» Articles » PMID: 20157752

The Cag PAI is Intact and Functional but HP0521 Varies Significantly in Helicobacter Pylori Isolates from Malaysia and Singapore

Overview
Publisher Springer
Date 2010 Feb 17
PMID 20157752
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Helicobacter pylori-related disease is at least partially attributable to the genotype of the infecting strain, particularly the presence of specific virulence factors. We investigated the prevalence of a novel combination of H. pylori virulence factors, including the cag pathogenicity island (PAI), and their association with severe disease in isolates from the three major ethnicities in Malaysia and Singapore, and evaluated whether the cag PAI was intact and functional in vitro. Polymerase chain reaction (PCR) was used to detect dupA, cagA, cagE, cagT, cagL and babA, and to type vacA, the EPIYA motifs, HP0521 alleles and oipA ON status in 159 H. pylori clinical isolates. Twenty-two strains were investigated for IL-8 induction and CagA translocation in vitro. The prevalence of cagA, cagE, cagL, cagT, babA, oipA ON and vacA s1 and i1 was >85%, irrespective of the disease state or ethnicity. The prevalence of dupA and the predominant HP0521 allele and EPIYA motif varied significantly with ethnicity (p < 0.05). A high prevalence of an intact cag PAI was found in all ethnic groups; however, no association was observed between any virulence factor and disease state. The novel association between the HP0521 alleles, EPIYA motifs and host ethnicity indicates that further studies to determine the function of this gene are important.

Citing Articles

CagA toxin and risk of Helicobacter pylori-infected gastric phenotype: A meta-analysis of observational studies.

Naing C, Aung H, Aye S, Poovorawan Y, Whittaker M PLoS One. 2024; 19(8):e0307172.

PMID: 39173001 PMC: 11341061. DOI: 10.1371/journal.pone.0307172.


Infiltration to infection: key virulence players of Helicobacter pylori pathogenicity.

Bhattacharjee A, Sahoo O, Sarkar A, Bhattacharya S, Chowdhury R, Kar S Infection. 2024; 52(2):345-384.

PMID: 38270780 DOI: 10.1007/s15010-023-02159-9.


Hp0521 inhibited the virulence of 26,695 strain via regulating CagA expression.

Yu M, Xu M, Shen Y, Liu Y, Xu C, Feng T Heliyon. 2023; 9(7):e17881.

PMID: 37539313 PMC: 10395286. DOI: 10.1016/j.heliyon.2023.e17881.


Efficacy and safety of bifidobacterium quadruple viable tablets in the treatment of Helicobacter pylori-infected peptic ulcer or gastritis patients: a systematic review and meta-analysis.

Jiang X, Xu C, Liu B, Chen P, Xu Q, Zhang L BMC Infect Dis. 2023; 23(1):313.

PMID: 37161358 PMC: 10170802. DOI: 10.1186/s12879-023-08211-1.


The heterogeneic distribution of Helicobacter pylori cag pathogenicity island reflects different pathologies in multiracial Malaysian population.

Hanafiah A, Razak S, Neoh H, Mohamad Zin N, Lopes B Braz J Infect Dis. 2020; 24(6):545-551.

PMID: 33157035 PMC: 9392095. DOI: 10.1016/j.bjid.2020.10.005.


References
1.
Rozen S, Skaletsky H . Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 1999; 132:365-86. DOI: 10.1385/1-59259-192-2:365. View

2.
Zambon C, Navaglia F, Basso D, Rugge M, Plebani M . Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia. J Clin Pathol. 2003; 56(4):287-91. PMC: 1769933. DOI: 10.1136/jcp.56.4.287. View

3.
Huang J, Zheng G, Sumanac K, Irvine E, Hunt R . Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology. 2004; 125(6):1636-44. DOI: 10.1053/j.gastro.2003.08.033. View

4.
Miehlke S, Kibler K, Kim J, Figura N, Small S, Graham D . Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. Am J Gastroenterol. 1996; 91(7):1322-5. View

5.
Hisatsune J, Nakayama M, Isomoto H, Kurazono H, Mukaida N, Mukhopadhyay A . Molecular characterization of Helicobacter pylori VacA induction of IL-8 in U937 cells reveals a prominent role for p38MAPK in activating transcription factor-2, cAMP response element binding protein, and NF-kappaB activation. J Immunol. 2008; 180(7):5017-27. PMC: 3404739. DOI: 10.4049/jimmunol.180.7.5017. View